Literature DB >> 30066158

Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.

Ritsuko Katafuchi1, Hiroshi Nagae2, Kosuke Masutani3, Kazuhiko Tsuruya4, Koji Mitsuiki5.   

Abstract

BACKGROUND: The clinicopathological significance of immunofluorescent findings in IgA nephropathy remains controversial.
METHODS: The relations of the deposition of IgA, IgG, IgM, C3, C1q and fibrinogen (Fib) with pathological findings, baseline clinical findings, and renal outcome were evaluated in 688 patients with IgA nephropathy. Pathological features included cellular or fibrocellular crescents, endocapillary or mesangial hypercellularity, segmental or global glomerulosclerosis and the Oxford classification.
RESULTS: The median age at biopsy was 30 years. There were 289 men. With 74 months median follow-up, 32% of patients received steroids. Twelve percent of patients developed end-stage renal disease (ESRD). The degree of IgA was closely related to the degree of C3, IgG and IgM deposition. The degree of IgA, C3, IgG and Fib deposition was significantly related to the percentage of glomeruli with crescent, endocapillary and mesangial hypercellularity. IgM deposition showed significant association with crescent, mesangial hypercellularity, segmental sclerosis, global glomerulosclerosis and tubular atrophy/interstitial fibrosis. In the patients treated with steroids, the risk for ESRD in patients with 2-3+ IgA deposition was significantly lower with reference of 1+ IgA deposition.
CONCLUSION: We found the different roles of glomerular immune reactants' deposition in the inflammatory process from acute to chronic stage. IgA deposition together with IgG, Fib and C3 may produce acute inflammatory injury. IgM deposition might occur in the early stage of inflammation and remains until late sclerotic stage. The prominent deposition of IgA related to low risk for ESRD in patients who received steroids might suggest effectiveness of steroids in such patients.

Entities:  

Keywords:  Complement deposition; IgA deposition; IgA nephropathy; IgG deposition; Immunofluorescent study

Mesh:

Substances:

Year:  2018        PMID: 30066158     DOI: 10.1007/s10157-018-1619-6

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  10 in total

1.  Predictive prognostic value of glomerular C3 deposition in IgA nephropathy.

Authors:  Minhua Xie; Yuze Zhu; Xutong Wang; Jingjing Ren; Haonan Guo; Bo Huang; Shulei Wang; Peiheng Wang; Yiming Liu; Yingchun Liu; Junjun Zhang
Journal:  J Nephrol       Date:  2022-07-04       Impact factor: 3.902

Review 2.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

3.  The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.

Authors:  Hideo Tsushima; Ken-Ichi Samejima; Masahiro Eriguchi; Takayuki Uemura; Hikari Tasaki; Fumihiro Fukata; Masatoshi Nishimoto; Takaaki Kosugi; Kaori Tanabe; Keisuke Okamoto; Masaru Matsui; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2022-04-15       Impact factor: 2.617

Review 4.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Authors:  Dana V Rizk; Nicolas Maillard; Bruce A Julian; Barbora Knoppova; Todd J Green; Jan Novak; Robert J Wyatt
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

5.  Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study.

Authors:  Lingzhi Wu; Di Liu; Ming Xia; Guochun Chen; Yu Liu; Xuejing Zhu; Hong Liu
Journal:  BMC Nephrol       Date:  2021-01-29       Impact factor: 2.388

6.  Clr-f expression regulates kidney immune and metabolic homeostasis.

Authors:  Haggag S Zein; Elias Abou-Samra; Michal Scur; Alex Gutsol; Clayton W Hall; Bishal Dasgupta; Lara Gharibeh; Turki Abujamel; Daniel Medina-Luna; Gayani S Gamage; Tessa J Pelino; Mona Nemer; Mir Munir A Rahim; Alexander Steinle; Brendon D Parsons; Andrew P Makrigiannis
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.996

7.  Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?

Authors:  Yizhen Chen; Aicheng Yang; Yuansheng Hou; Longhui Liu; Jiehua Lin; Xiaodan Huang; Jundu Li; Xusheng Liu; Fuhua Lu; Qizhan Lin; Haifeng Yang; Shuling Yue; Shujun Jiang; Lixin Wang; Chuan Zou
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

8.  IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis.

Authors:  Yuki Mitarai; Kazuhisa Nakashima; Shohei Fukunaga; Noriyoshi Ishikawa; Takafumi Ito; Yukari Tsubata; Takeshi Isobe
Journal:  Intern Med       Date:  2021-11-27       Impact factor: 1.282

Review 9.  The Role of Immune Modulation in Pathogenesis of IgA Nephropathy.

Authors:  Sheng Chang; Xiao-Kang Li
Journal:  Front Med (Lausanne)       Date:  2020-03-24

10.  Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy.

Authors:  Yuko Shima; Koichi Nakanishi; Hironobu Mukaiyama; Yu Tanaka; Takuzo Wada; Ryojiro Tanaka; Hiroshi Kaito; Kandai Nozu; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2020-10-04       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.